Prolifagen
Overview
According to the Center for Disease Control (CDC), 805,000 Americans suffered a heart attack in 2025. 200,000 of those heart attacks were repeat heart.
Funding and backers
Total raised
$3M
1 round on record
Latest round
$3M
Venture round · Sep 2025 · 14 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
14 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2025 | $3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Prolifagen, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Claudine BruckExecutive Officer, DirectorSEC Form D
Michael BehrExecutive Officer, DirectorSEC Form D
William HoustonExecutive OfficerSEC Form D
Andreas BaderExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Search: OVERVIEW Cellular Logistics, a pioneering biotech company, has developed CFX™, an innovative cardiac therapy aimed at promoting…
Implant-free cryotherapy. Solutions to stabilize vulnerable plaques and reduce heart attack risk.
Life-saving heart attack prevention. Improve patient outcomes with precision cardiology imaging.
Xenter transforms medical devices with Physical Intelligence technology, wirelessly transmitting real-time clinical data to improve…
Powerful Medical is a Slovak health technology company founded in 2019 and headquartered near Bratislava. Its PMcardio software interprets…
CoFI System Learn More CoFI System Learn More What is the importance of identifying and addressing microvascular disease, and specifically…
Financials
Total raised
$3M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $3M | Details |
People
Claudine Bruck
Executive Officer, Director
Michael Behr
Executive Officer, Director
William Houston
Executive Officer
Andreas Bader
Executive Officer
M. Shaw
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
Headline for Article or News with Potentially Long Medical Titles
Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi archit
Read more
Report
Prolifagen Announces Leadership Team
Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi archit
Read more
Report
Scientific Advances in Regenerative Cardiac Muscle Tissue
Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi archit
Read more
Report
Headline for a Short Post
Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi archit
Read more
Report
Prolifagen Therapeutics Appoints M. Alexander Shaw, PhD, as Chief Executive Officer
/PRNewswire/ -- Prolifagen Therapeutics, a biotech startup developing medicines for cardiac regeneration, has appointed M. Alexander Shaw, PhD, as Chief...
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Doylestown
United States
HQ
50-200 est. staff